Page last updated: 2024-08-21

pyrazines and Adenocarcinoma, Clear Cell

pyrazines has been researched along with Adenocarcinoma, Clear Cell in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Jiang, H; Jiang, S; Li, X; Liang, C; Liu, L; Ruan, T; Song, J; Ye, H; Zhang, Y; Zhuo, C	1

Other Studies

1 other study(ies) available for pyrazines and Adenocarcinoma, Clear Cell

Article	Year
OSI-906 restores the sensitivity of ovarian clear cell carcinoma to cisplatin by targeting the IGF1R/AKT pathway. Medical oncology (Northwood, London, England), 2022, Jan-04, Volume: 39, Issue:2 Topics: Adenocarcinoma, Clear Cell; Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cisplatin; Drug Resistance; Female; Imidazoles; Mice, Inbred BALB C; Mice, Nude; Ovarian Neoplasms; Proto-Oncogene Proteins c-akt; Pyrazines; Receptor, IGF Type 1; Signal Transduction	2022

Article

Year

OSI-906 restores the sensitivity of ovarian clear cell carcinoma to cisplatin by targeting the IGF1R/AKT pathway.

Medical oncology (Northwood, London, England), 2022, Jan-04, Volume: 39, Issue:2

Topics: Adenocarcinoma, Clear Cell; Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cisplatin; Drug Resistance; Female; Imidazoles; Mice, Inbred BALB C; Mice, Nude; Ovarian Neoplasms; Proto-Oncogene Proteins c-akt; Pyrazines; Receptor, IGF Type 1; Signal Transduction

2022